Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine SERT Binding in Depression
NCT02717052Phase 2Unknown
- Sponsor
- Medical University of Vienna
- Start
- May 2016
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in major depressive disorder (MDD), sponsored by Medical University of Vienna. Status: unknown.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02717052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02717052.